Mutation of MLL3 results in the defect of BRCA1 associated protein 1 (BAP1) recruitment to the enhancers of tumor-suppressor genes, which represses enhancer activity and promotes tumorigenesis19. This evidence concerns the gene KMT2C and neoplasm.